Ads
related to: pancreatic cancer, cancer treatment- Dosing & Administration
Find Important Dosing, Modification
& Administration Info for Providers
- Contact a Specialist
HCPs: Get In Touch with an Oncology
Account Specialist for More Info
- Clinical Efficacy, Safety
See Efficacy Results & Study Info
for This Treatment Option
- Resources For Oncologists
Download Dosing Guide, Watch Videos
and More for Providers
- Read The Patient Brochure
Help Patients Take An Active Role
During Treatment. Download & Share.
- Important Safety Info
Read important safety information
About this treatment
- Dosing & Administration
Search results
EPI flare-ups: What triggers them and how to manage
Medical News Today· 7 days agoTriggers of exocrine pancreatic insufficiency (EPI) can include diet, alcohol, stress, infection, or a preexisting health condition. Managing flare-ups might require medication ...
Hiker in cardiac distress rescued from Great Smoky Mountains National Park
WATE 6 Knoxville· 6 days agoA Tennessee National Guard flight crew rescued a hiker in cardiac distress from the Great Smoky...
Entrada Therapeutics (NASDAQ:TRDA) versus BioLineRx (NASDAQ:BLRX) Head to Head Comparison
ETF DAILY NEWS· 6 days agoBioLineRx (NASDAQ:BLRX – Get Free Report) and Entrada Therapeutics (NASDAQ:TRDA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast ...
Autonomix appoints new CEO, shifts former leader to board By Investing.com
Investing.com· 3 days agoAutonomix Medical, Inc. (NASDAQ: AMIX), a company specializing in medical devices for neurological...
Hounslow: Sick refugee grandad 'forced to sleep on floor'
BBC News· 4 days agoA woman from Hounslow, west London, says a council has left her family in a "severely overcrowded"...
Ceftazidime is a potential drug to inhibit cell proliferation by increasing cellular p27 - The...
Nature· 2 days agoThe development of new therapeutic uses for existing drugs is important for the treatment of some diseases. Cephalosporin antibiotics stand as the most extensively utilized ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Downgraded by UBS Group
ETF DAILY NEWS· 17 hours agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report) was downgraded by UBS Group from a “buy” rating to a “neutral” rating in a report issued on Thursday, Briefing.com reports. UBS Group ...
Oppenheimer Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $25.00
ETF DAILY NEWS· 2 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective trimmed by Oppenheimer from $50.00 to $25.00 in a report issued on Tuesday morning, Benzinga reports. Wells Fargo ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Downgraded by Wedbush
ETF DAILY NEWS· 2 days agoWedbush downgraded shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from a neutral rating to an underperform rating in a research report sent to investors on Tuesday morning, MarketBeat ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) PT Lowered to $20.00 at HC Wainwright
ETF DAILY NEWS· 2 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective cut by HC Wainwright from $40.00 to $20.00 in a report issued on Tuesday morning, Benzinga reports. Stifel Nicolaus ...